Similar Search Results

The pricing of successful venture capital-backed high-tech and life-sciences companies

In: Journal of business venturing 13 (1998) 5, pp. 333-351

Persistent link: https://www.econbiz.de/10001246769

Stock market response to strategic technical alliances between drug and biotechnology firms

Liu, Dandan; Pu, Xiaoling; Schramm, Mary E. - In: The journal of product innovation management : an … 33 (2016) 5, pp. 549-569

Persistent link: https://www.econbiz.de/10011600397

Risks to the returns to medical innovation : the case of Myriad Genetics

Clemens, Jeffrey; Veuger, Stan - 2015

Persistent link: https://www.econbiz.de/10011336574

Risks to the returns to medical innovation : the case of Myriad genetics

Clemens, Jeffrey; Veuger, Stan - In: Contemporary economic policy : a journal of Western … 35 (2017) 2, pp. 345-357

Persistent link: https://www.econbiz.de/10011918892

Constraints on large-block shareholders

Holderness, Clifford G.; Sheehan, Dennis P. - 1998

Persistent link: https://www.econbiz.de/10000679938

Why managers hold shares of their firms : an empirical analysis

Lilienfeld-Toal, Ulf von (contributor); … - 2007

We examine the relationship between CEO ownership and stock market performance. Firms in which the CEO voluntarily holds a considerable share of outstanding stocks outperform the market by more than 10% p.a. after controlling for traditional risk factors. The effect is most pronounced in firms...